AI in myeloproliferative neoplasms can grade marrow fibrosis and predict survival, but authors say prospective, ...
Home-based oncology transforms practice transformation with clear bagging, protecting Medicare reimbursement, provider ...
UChicago Medicine’s Obada Shamaa, MD, PhD, discusses why bronchiectasis is underrecognized and how to personalize airway ...
PBM reform, Medicare Advantage exits, and the 340B rebate pilot are reshaping drug access. Here is what payers need to know ...
Kidney Week 2026 brought strong IgAN data, looked back on 5 years of value-based kidney care, and highlighted evidence of ...
October's FDA approvals brought notable advances beyond oncology, adding new treatment options in allergy and immunology, ...
Costs of multimorbidity in older adults are climbing faster than its disability toll, and study authors say policy should ...
Oncologists reveal why breakthrough cancer drugs still stall—referral gaps, payer delays, caregiver needs, and pharmacy ...
Bipolar disorder often goes undiagnosed for years, and clinicians need to separate mood episodes from normal emotions and ...
Meta-analysis suggests off-label upadacitinib drives major alopecia areata hair regrowth and SALT score gains, but phase 3 ...
A gradient boosting model identified MASLD in lean adults with an AUC of 0.779, using 8 routine clinical measurements.
Bipolar disorder can take 5 to 10 years to diagnose, and missing it can harm patients’ jobs, relationships, finances, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results